| 번호 | 논문제목 | 저자 | 학술지 | 게재일 |
|---|---|---|---|---|
| 1863 | Perinatal Exposure to Di(2-ethylhexyl) Phthalate Induces Hydronephrosis and Glomerular Filtration Barrier Injury in Mouse Offspring | 자히르 자베리아(방사성의약품개발팀,50%) | Journal of Hazardous Materials Advances | 2026-06-25 |
| 1862 | Experimental determination of scaling factor for poly-lactic acid plastic phantom made using FFF 3D printing in electron dosimetry | 최요나(방사선조사담당,50%) | Radiation Physics and Chemistry | 2026-06-02 |
| 1861 | The Prevalence of BRAF Mutation in Papillary Thyroid Carcinoma Significantly Decreased as Tumor Size Increased | 임다은(내분비내과,60%) | International Journal of Thyroidology | 2026-05-30 |
| 1860 | Chemotherapy-Related Cognitive Impairment as a Crisis of the Self: A Winnicottian Psycho-Oncological Perspective | 강선미(건국대학교,51%) | Frontiers in Psychology | 2026-05-14 |
| 1859 | A 64Cu-Labeled Oxopurine Derivative for Translocator Protein Targeted Inflammation Imaging | 이크라 비비(방사성의약품개발팀,15%), 오질수호 온드람(RI인프라응용팀,15%) | Journal of Labelled Compounds and Radiopharmaceuticals | 2026-05-14 |
| 1858 | Ultra-high dose rate electron FLASH beam irradiation using a modified clinical linear acclerator | 조규석(방사선치료기술표준팀,20%), 김교태(GEMSS Healthcare,20%) | PLOS ONE | 2026-04-17 |
| 1857 | A Case of Tuberculous Otitis Media Diagnosed Before Surgery and Treated Successfully With Anti-Tuberculosis Medication | 권창훈(교육수련부,45%) | Korean J Otorhinolaryngol-Head Neck Surg | 2026-04-13 |
| 1856 | OnlyOncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer | 윤아름(한양대학교,20%), 김승연(방사성의약품개발팀,20%) | Journal for ImmunoTherapy of Cancer | 2026-04-09 |
| 1855 | Treatment of cervical/vaginal intra-epithelial neoplasia with high?dose-rate brachytherapy: a multi-center retrospective analysis | 김동윤( 고려대안암병원원/방사선종양학과 ,16%), 이충원( 서울대병원/방사선종양학과 ,16%), 정원근( 이대목동병원/방사선종양학과 ,16%) | International Journal of Gynecological Cancer | 2026-04-06 |
| 1854 | Human bone marrow niche organoids for disease modeling and therapeutic application in hematopoietic syndrome | 박희빈(서울여자대학교/바이오헬스융합학과,14%), 유인선(서울여자대학교/바이오헬스융합학과,13%), 김태진(방사선바이오소재개발팀,13%) | Biomaterials | 2026-04-01 |
논문
혁신적 암치료를 선도하는 세계 방사선의학의 중심, 한국원자력의학원
-
- 현재 페이지의 화면이 이해하기 쉽게 구성되어 사용하기에 편리합니까?
-
- 현재 페이지에서 원하는 기능이 충분히 제공되었습니까?
-
- 사용자가 원하는 페이지를 쉽게 찾을 수 있었습니까?
평가하기